Ascendis Pharma · 4 months ago
Rare Conditions Account Manager (Southeast) - Job ID: 1707
Maryland, United States
Full-time
Onsite
Senior Level
$195K/yr - $215K/yr
5+ years expAscendis Pharma is a dynamic, fast-growing global biopharmaceutical company focused on advancing programs in Endocrinology, Rare Disease, and Oncology. They are seeking a Rare Conditions Account Manager to lead key relationships in the rare disease space, focusing on demand generation within the Rare Conditions portfolio and engaging with healthcare professionals and stakeholders within top centers of excellence.
BiotechnologyClinical TrialsHealth Care
Responsibilities
Responsible for demand generation within the Rare Conditions product portfolio and be accountable to develop expert product and disease state knowledge that allows them to engage in appropriate face-to-face clinical dialogue with healthcare professionals
Effectively promote approved indications and product efficacy/safety profiles to support on-label prescribing for appropriate patients
Develop and execute a territory business plan to achieve or exceed sales goals
Establish strategic relationships with key stakeholders in assigned centers of excellence & academic institutions that include physicians, administrative staff, nurses, care coordinators, and pharmacists to drive adoption of Ascendis products
Lead cross-functional planning efforts to optimize access and adoption of rare disease therapies and identify referral networks within assigned customer segments
Work collaboratively internal teams (Patient Services, Marketing, Medical Affairs, HEOR, Market Access) to ensure alignment of goals and execution
Provide field insights on emerging treatment trends, patient’s needs, and competitor activity to internal stakeholders
Stay current on rare disease market trends, policy developments (e.g., orphan drug policy), patient advocacy, and competitive activity
Experience launching or supporting ultra rare disease products
Strong understanding of specialty drug (rare/orphan disease) environment to ensure customers’ and patients’ needs
Ability to travel 70% and cover a large geographic area
Qualification
Required
Bachelor's degree required; advanced degree preferred
5+ years of experience in strategic account management, market access, or health system-based sales in the rare disease, biotech, or specialty pharma sector
Proven ability to engage and influence high level stakeholders in key centers of excellence and academic institutions establishing measurable impact on product access and revenue growth
Demonstrated use of product knowledge to engage in customized discussions and in-person interactions based on customer's needs in a compliant and ethical manner
Documented track record of consistent top performance
Strong knowledge of rare disease market dynamics, including distribution, patient support, high-touch care coordination, and innovative reimbursement models
Exceptional communication, negotiation, and executive presentation skills
Strong clinical and business acumen with the ability to craft compelling clinical patient focused solutions
Proficiency with CRM tools (e.g., Salesforce) and strategic account planning frameworks
Preferred
Familiarity with integrated delivery networks (IDNs), PBMs, and specialty pharmacy operations
Proven success of balancing a product portfolio
Benefits
401(k) plan with company match
Medical, dental, and vision plans
Company-offered Life and Accidental Death & Dismemberment (AD&D) insurance
Company-provided short and long-term disability benefits
Unique offerings of Pet Insurance and Legal Insurance
Employee Assistance Program
Employee Discounts
Professional Development
Health Saving Account (HSA)
Flexible Spending Accounts
Various incentive compensation plans
Accident, Critical Illness, and Hospital Indemnity Insurance
Mental Health resources
Paid leave benefits for new parents
Company
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.88BKey Investors
Royalty Pharma
2024-09-19Post Ipo Equity· $300M
2024-09-03Post Ipo Debt· $150M
2023-09-05Post Ipo Debt· $150M
Leadership Team
Ivanna Rosendal
Senior Director, IT Business Partner
Keren Tenenbaum
US General Counsel and Chief Compliance Officer
Recent News
2026-01-11
2026-01-11
Company data provided by crunchbase